About us

Executive board

Scientific advisory board

---

Prof. Paul Lecoq, PhD, Chairman of the Board & CEO

• Graduated as Engineer in Physics Instrumentation at the Ecole Polytechnique of Grenoble under the leadership of Nobel Laureate Louis Néel
• PhD in Nuclear Physics (Nuclear Physics Laboratory of the University of Montreal, Canada)
• Head of Physics Division at the European Academy of Sciences
• Doctor Honoris Causa at the Polytechnic University of Valencia, Spain
• Doctor Honoris Causa at the Kharkhiv Institute of Single Crystals (Ukraine Academy of Sciences)
• Founder of the Crystal Clear Collaboration & of CERIMED (European Center for Research in Medical Imaging)  

Paul dedicated his 40 year career to the field of medical physics at CERN, the European Organization for Nuclear Research.

His work on particle physics detectors focused on applications in medical imaging. His research findings continue to inspire several groups around the world working on improving the sensitivity and performance of PET scanners. His work on detector instrumentation and particularly on heavy inorganic scintillator materials has received strong support from Nobel Laureates, Carlo Rubia and Georges Charpak. While at CERN, his work played an important role in the discovery of the Higgs boson.

In 2019, Paul became co-CEO of a newly created subsidiary of Multiwave Technologies SA. In 2024, he leaded the spin off of METACRYSTAL SA (formerly called Multiwave Metacrystal SA) and became CEO.

Georgios Konstantinou, PhD, CTO & member of the Board

• Diploma in electronic engineering at National Technical University of Athens
• PhD in Medical Physics at Universidad Carlos III Madrid
• Marie Sklodowska Curie grant

Georgios started his career in 2009 at CERN, developing electronics for both low-level RF control for the proton synchrotron, the accelerator feeding particles to the LHC, as well as for the straw tracker of the ultra-rare kaon experiment NA62.

Being interested in all aspects of technology, Georgios spent a year as a patent examiner at the European Patent Office.

He left EPO to found his own startup, SensYnc, in 2019 on the development of a commercial PET system.

Georgios joined Multiwave Metacrystal SA as CTO after the acquisition of SensYnc by Multiwave Metacrystal SA. At Multiwave Metacrystal, Georgios leads the analysis, testing and development of metamaterial-based ultra-fast block detectors for positron emission tomography.

Georgios participated in the European Institute for Innovation and Technology Healthcare network.

Catherine Lefèvre, CFO, Business Manager & member of the Board

• Graduated as Engineer at the Ecole Nationale de l’Aviation Civile in Toulouse, France
• Graduated from Institut d’Etudes Politiques (Economy & Finance) in Paris, France

After having held positions in the banking sector, Catherine served in mid-cap companies as CFO & Secretary-general. She is presently an independent consultant in business development and operational strategy. She is member of several board of directors.

José María Benlloch, Chairman of the Scientific Advisory Board

• PhD in Nuclear Physics (DELPHI collaboration of the LEP accelerator at CERN)
• Full Professor at the Spanish National Research Council (CSIC)
• Founder and Director of the Institute for Instrumentation of Molecular Imaging (I3M) at the Polytechnic University of Valencia, Spain
• Received from Felipe VI, King of Spain, the National Research Award « Leonardo Torres Quevedo » in 2014, and from Juan Carlos I, former King of Spain, the « Rey Jaime I » award in 2008.

José María worked in particle detectors at CERN (Geneva, Switzerland and at the Fermi National Accelerator Laboratory (Chicago, USA).

Later, he was member of the CDF collaboration that discovered in 1995 the top quark, one of the 12 elementary particles. He worked as Staff member of the Massachussetts Institute of Technology under the direction of Jerome Friedman (Nobel Laureate in Physics, 1990).

In 1996, José María came back to CERN in order to perform research on radiation detectors in the groups of F. Sauli and T. Ypsilantis. When he returned to Spain in 1999, he started a research group on Medical Imaging. Since then, he has developed several medical imaging diagnostic devices based on the detection of gamma rays, X-rays, and magnetic resonance.

Author of around 300 articles in international peer reviewed publications. Advisor of 10 PhD theses. Author of more than 20 patents related to imaging equipment for medical diagnosis.

Antonio J. González, member of the Scientific Advisory Board

• Physics Degree in 2002 at the University of Valencia
• PhD in 2005 at the University of Heidelberg in Germany : the work, entitled “Quantum interference in the dielectronic recombination of heavy highly charged ions”, was carried out at the Max Planck Institute for Nuclear Physics in Heidelberg.

Antonio is a researcher at the Spanish National Research Council (CSIC), with a permanent position since 2017, working on the development of molecular imaging systems since 2006.

Since about 2006, Antonio has built PET prototypes in the preclinical small animal field and also in the clinical site. He has made a concerted effort to focus on imagers using monolithic crystals. The devices developed have been successfully transferred to the industry such as the small animal PET Albira, currently distributed by Bruker, or the dedicated breast PET commercialized by Oncovision. Antonio has scientifically led two EU grants, the breast-dedicated PET MAMMI and currently the brain PET insert called MINDView. In 2020 He was awarded with two NIH projects namely an R01 as co-PI (1R01EB029450-01) and an R21 in collaboration with University of Washington (EB028420-01). In the first, a novel preclinical PET insert for 9T MRI has been constructed. In 2023 Antonio been awarded with another R01 as co-PI together with the Weill Medical Center at Cornell in NY. In 2022-2023 he managed the design and built of the first TB-PET with DOI and TOF capabilities, installed in Valencia (Spain). Very recently he has been awarded with a grant from the Valencian region to develop a PET scanner for dosimetry estimations after proton therapy.

He has over 100 peer-reviewed papers in high impact journals. Antonio has an h-index of 28. He has filled for 13 patents, most of them licenced. He has successfully directed 10 PhD theses and is currently supervising 5 more concerning about the design of a gamma ray detectors, eventually MR compatible.

Paul Schotanus, member of the Scientific Advisory Board

Dr. Paul Schotanus started his work on scintillation materials at the Delft University of Technology under Prof. Carel Van Eijk. His subject was the luminescence properties of barium fluoride applied to positron emission tomograpy . Later he worked on several projects at universities (University Utrecht, TU eindhoven) on the application of scintillation materials in various physics projects. His interest is the design and use of dedicated scintillation sensors in science, industry, medicine end security. He gives webinars, lectures and courses on the optimum use of scintillation crystals in all above mentioned fields and is managing director of SCIONIX Holland.